Retraction
MicroRNA-137 acts as a tumor suppressor in osteosarcoma by targeting enhancer of zeste homolog 2
Paper Information
Record ID:
32305
Author(s):
Journal:
Publication Date:
May 05, 2017
Retraction Date:
August 12, 2021
(4.3 years years ago)
Subjects:
Institutions:
- Nursing School, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
- Department of Orthopedics, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
- Department of Orthopedics, Jing An Hospital, Yichun, Jiangxi 330600, P.R. China
- Department of Immunology and Microbiology, Medical School of Jishou University, Jishou, Hunan 416000, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations3
Post-Retraction(23.1%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
630
Days since retraction (latest)
The microRNA-137 was predicted to regulate the mitogen-activated protein kinases and pluripotency-related pathways in the MDA-MB-231 cells
Ruth Ruiz Esparza‐Garrido, Andrea Viridiana Cervantes Ayala, Miguel Ángel Velázquez-Flores
International Journal of Biological and Natural Sciences
Open Access
Published: May 2023
630 days after retraction
miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer
Yutu Luo, Su-Wei Hu, Fang Wang et al. (8 authors)
Translational Cancer Research
Open Access
Published: Oct 2022
7 citations
7 citations
415 days after retraction
Prognostic Value of miR-137 in Children with Medulloblastoma and its Regulatory Effect on Tumor Progression
Wenyuan Ji, Zhe Xuan, Lusheng Li et al. (8 authors)
NeuroMolecular Medicine
Published: Aug 2021
3 citations
3 citations
6 days after retraction
Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137
Dan Li, Yan Huang, Gang Wang
BioMed Research International
Open Access
Published: Apr 2021
25 citations
25 citations
111 days before retraction
Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma
Xingxing Sun, Cong Tian, Hui Zhang et al. (8 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: May 2020
35 citations
35 citations
445 days before retraction
miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4
Feiya Du, Ling Yu, Ying Wu et al. (11 authors)
Cell Death and Disease
Open Access
Published: Dec 2019
62 citations
62 citations
617 days before retraction
<p>Knockdown Of lncRNA NCK-AS1 Regulates Cisplatin Resistance Through Modulating miR-137 In Osteosarcoma Cells</p>
Yi Cheng, Xiaofei Shen, Minqian Zheng et al. (5 authors)
OncoTargets and Therapy
Open Access
Published: Dec 2019
30 citations
30 citations
620 days before retraction
miRNA signatures in childhood sarcomas and their clinical implications
G. M. Viera, Karina Bezerra Salomão, Graziella Ribeiro de Sousa et al. (7 authors)
Clinical & Translational Oncology
Published: Apr 2019
15 citations
15 citations
861 days before retraction
Long non‑coding RNA XIST serves an oncogenic role in osteosarcoma by sponging miR‑137
Hui Li, Jingjing Cui, Bin Xu et al. (6 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Nov 2018
19 citations
19 citations
987 days before retraction
Participación del miR-137 en el cáncer
AV Cervantes-Ayala, Ruth Ruiz Esparza‐Garrido, Má Velázquez-Flores
Unknown Journal
Published: Aug 2018
1091 days before retraction
Establishment of an miR‑137‑knockout cell model using CRISPR/Cas9 genome editing
Wei Chen, Qi Li, Jingjie Du et al. (6 authors)
Oncology Letters
Open Access
Published: Jul 2018
5 citations
5 citations
1133 days before retraction
miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase
Wenkang Luan, Zhou Zhou, Yan Zhu et al. (6 authors)
Biochemical and Biophysical Research Communications
Published: Oct 2017
35 citations
35 citations
1381 days before retraction
MicroRNA-139 inhibits the proliferation and migration of osteosarcoma cells via targeting forkhead-box P2
Chunan Zhong, Jijun Liu, Yuzhe Zhang et al. (5 authors)
Life Sciences
Published: Oct 2017
17 citations
17 citations
1400 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025